Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma
Radiation Oncology Journal. 2020;38(1):35-43 
Low-Dose Whole Brain Radiotherapy with Tumor Bed Boost after Methotrexate-Based Chemotherapy for Primary Central Nervous System Lymphoma
Cancer Research and Treatment. 2014;46(3):261-269
A rare case of paediatric primary central nervous system lymphoma treated with high-dose methotrexate and rituximab-based chemoimmunotherapy and whole brain radiotherapy followed by tumour bed boost with three-dimensional conformal radiation technique
Child's Nervous System. 2018;34(9):1777-1783
PD-0171: Reduced-Dose Whole Brain Radiotherapy for the Primary Central Nervous System Lymphoma
Radiotherapy and Oncology. 2020;152:S83
A phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma
Annals of Oncology. 2018;29:ix22
Chemotherapy for Primary Central Nervous System Lymphoma
Handbook of Brain Tumor Chemotherapy. 2006;395-406
8727 Outcome after high-dose methotrexate and radiotherapy for primary central nervous system lymphoma
European Journal of Cancer Supplements. 2009;7(2):501
P05.90 A prospective phase II study of whole brain radiotherapy concomitant to Temozolomide in primary central nervous system lymphoma after high dose methotrexate
Neuro-Oncology. 2018;20(suppl_3):iii324-iii325
A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy
Pediatric Neurosurgery. 2019;54(1):57-65
Primary Central Nervous System Lymphoma: Treatment with High-Dose Methotrexate
Tumors of the Central Nervous System, Volume 9. 2012;55-66